Table 1 Demographic and clinical characteristics of the participants (n = 572)
Characteristics / variable | Total sample (n = 572a) |
|---|---|
Age, Mean (Median, Range) | 77.2 (80, 32 to 102) |
Sex, Female n (%) | 264 (46.2) |
Ethnicity, n (%) | |
White (British and Other) | 436 (79.9) |
Otherb | 110 (20.1) |
BMI, n (%) | |
Underweight (< 18.5) | 96 (20.3) |
Healthy (24.9–18.5) | 201 (42.4) |
Overweight (29.9–25) | 110 (23.2) |
Obese (> 30) | 67 (14.1) |
Status at Baseline, n (%) | |
New to Palliative Care services | 75 (13.1) |
Already supported by palliative care services | 496(86.9) |
Number of IPOS-COV symptoms recorded at Baseline Mean (Median, Range) | 4.9 (5, 0 to 12) |
Baseline AKPS Score, Mean (Median, Range) | 24.3 (20, 10 to 90) |
Assessments: | |
Baseline Oxygen Saturation (%) Mean (Median, Range) | 90.4 (93,48 to 100) |
Baseline C-reactive Protein, n, Mean (Median, Range) mg/L | 436, 141.4 (120.5, 2 to 449) |
Baseline D-dimer test valuec, n, Mean (Median, Range) µg/L | 103, 3679.3 (1630, 36.1 to 67,010) |
Baseline Lymphocyte countd, n, Mean (Median, Range(109L) | 1 (0.8, 0.1 to 17.5) |
Baseline Lactate Dehydrogenasee, n, Mean (Median, Range) U/L | 57, 1483 (539, 111 to 43,893) |
Phase of Illness at Baseline Assessment n (%) | |
Stable | 17 (3) |
Unstable | 171 (30.3) |
Deteriorating | 151 (26.7) |
Dying | 226 (40) |
Outcome at the end of the study observation and follow-up period, n (%) | |
Died | 417 (73) |
Discharged or Still in Care | 154 (27) |
Patients admitted at waves of COVIDf, n (%) | |
Wave 1 (February 2020—August 2020) | 316 (61.4) |
Wave 2 (September 2020—February 2021) | 199 (38.6) |